Diovan (Blood Pressure Drug) Cuts Risk of Diabetes, Especially in High-Risk GroupMay 18th, 2005 Valsartan, commercially known as Diovan, a drug that controls blood pressure and reduces heart risk, also appears to protect against diabetes, especially in high-risk people, according to new research presented at the American Society of Hypertension's Twentieth Annual Scientific Meeting and Exposition (ASH 2005) by a University of Michigan physician who helped lead the study. The randomized trial involved 15,313 patients at 942 sites in 31 countries, of whom 9,995 did not have diabetes at the start of the study.
Research indicates waist circumference is the strongest indicator of type 2 diabetes risk in menApril 2nd, 2005 According to the team, as waist circumference increased, so did the risk of developing diabetes, with the risk in men with the highest waist circumference (up to 158 centimeters) increasing by 12-fold, they report. "Our findings support the contention that the measurement of waist circumference should be used in clinical practice instead of waist-to-hip ratio," the investigators write.
FDA OK's Cholesterol Drug Lipitor for DiabeticsSeptember 27th, 2005 Pfizer Inc. said U.S. regulators (FDA) have approved its cholesterol lowering drug Lipitor. Lipitor is used to reduce the risk of stroke and heart attack in diabetic patients.
Do you have diabetes? Are you sure?April 5th, 2005 According to University of Washington about 10 million US citizens have diabetes without being aware of it. Diabetes is the most insidious disease.
Link between Fat Tissue and Diabetes DiscoveredAugust 9th, 2005 Overweight or obese has long been recognized as a risk factor for type 2 diabetes. The results of a new study are clarifying the nature of the link between weight and diabetes.
Pizza's are Bad News for DiabeticsJuly 17th, 2005 "Keeping glucose levels from jumping too high or dipping too low may help to reduce the risk of cardiovascular disease, which has been connected to erratic glucose levels in those with diabetes," said Robert Gabbay, MD, Ph.D., associate professor of medicine, Penn State College of Medicine, Penn State Milton S. Hershey Medical Centre, and co-director, Penn State Diabetes Centre.
10 Minute Survey to Life ExpectancySeptember 7th, 2005 A simple ten minute survey to determine your life expectancy. It says about me:
In an extremely high risk overweight category, meaning you are at extremely high risk for obesity-related illnesses such as heart disease, high blood pressure, stroke and cancer.
Diabetes Cure PossibleJune 18th, 2006 Cure for diabetes could be around the corner after US scientists found cells from the spleen can transform into insulin-producing cells. US researchers were able to halt, and even reverse, the disease in mice.
Arabs face higher risk of diabetesApril 13th, 2005 According to a study by Arab Community Center for Economic and Social Services in cooperation with Wayne State University -
People of Arab descent are at significantly greater risk of diabetes than the general population and use tobacco at high rates, especially among younger people, in part because of the smoking of "argila," a traditional communal pipe. Nationally, 18.3 percent of Arabs are diabetics, compared to about 13 percent of African-Americans, 12 percent of Latinos and 4 percent of Caucasians.
Excessive Sleepiness May Signal Depression, Diabetes or ObesitySeptember 7th, 2005 Doctors commonly view excessive daytime sleepiness as a cardinal sign of disturbed or inadequate sleep. But a new study suggests it could also signal depression or even diabetes or obesity, regardless of whether an individual doesn't sleep well.
Ruboxistaurin (RBX) May Reduce Risk of Vision Loss in DiabeticsJuly 16th, 2005 A multicenter international study chaired by a Joslin Diabetes Center investigator and reported in the July issue of the American Diabetes Association’s journal Diabetes brings hopeful news to the 18 million people in the United States -- and millions more worldwide -- with type 1 or type 2 diabetes. Initial results of the Phase III clinical trial demonstrated that 32 milligrams per day of ruboxistaurin (RBX) was well tolerated and may reduce the risk of moderate vision loss, especially in patients with diabetic macular edema.
Single Insulin Regulator Gene Linked to Obesity and DiabatesJuly 18th, 2005 A gene that may regulate the body's response to insulin has been linked to both obesity and type-2 diabetes, researchers in Britain and France reported on Monday. Scientists found 11 different variations of the gene, called single nucleotide polymorphisms or SNPs.
Pet Owners Warned of Diabetes RiskJuly 17th, 2005 The RSPCA is urging pet owners to be aware of diseases that pets can have that are normally not associated with animals like diabetes. Amid National Diabetes Week, the RSPCA says even though it is a rare disease in animals, it can still happen.
Every 1 in 2 Indian Corporates are Unhappy. Are you in or Out?April 6th, 2009 More than half of corporate India's workforce suffers from various chronic and lifestyle diseases, with those in the information technology (IT) and IT-enabled services (ITES), media, knowledge process outsourcing (KPO) and financial services topping the list, says an industry group report.A study by the Associated Chambers of commerce and Industry of India (Assocham), said 54 percent of the workforce in the IT and ITES sectors were afflicted with depression, severe headaches, obesity, chronic backache, spondylosis, diabetes and hypertension. It said of them, 23 percent suffered from spondylosis, 20 percent from sleeping disorder and 18 percent from obesity.
Gene expression inhibitor drug made mice (STZ induced) diabetes resistantMarch 21st, 2005 Researchers from North Shore-Long Island Jewish Health System in Manhasset, N.Y. have identified a gene which expresses as a protein called macrophage migration inhibitory factor, or MIF.